OpenURL Connection Search

Select item for more details and to access through your institution.

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
By:
- Christofides, Elena A.;
- Puente, Orlando;
- Norwood, Paul;
- Denham, Douglas;
- Maheshwari, Hiralal;
- Lillestol, Michael;
- Hart, Terence;
- Nakhle, Samer;
- Chadha, Anurekha;
- Fitz‐Patrick, David;
- Sugimoto, Danny;
- Soufer, Joseph;
- Young, Douglas;
- Warren, Mark;
- Huffman, David;
- Reed, John;
- Bays, Harold;
- Arora, Samir;
- Rizzardi, Barbara;
- Tidman, Raymond
Publication type:
Article
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Published in:
Arthritis & Rheumatology, 2017, v. 69, n. 1, p. 203, doi. 10.1002/art.39840
By:
- Saag, Kenneth G.;
- Fitz‐Patrick, David;
- Kopicko, Jeff;
- Fung, Maple;
- Bhakta, Nihar;
- Adler, Scott;
- Storgard, Chris;
- Baumgartner, Scott;
- Becker, Michael A.
Publication type:
Article
Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials.
Published in:
Modern Rheumatology, 2019, v. 29, n. 6, p. 1042, doi. 10.1080/14397595.2018.1538003
By:
- Fitz-Patrick, David;
- Roberson, Kent;
- Kiyoshi Niwa;
- Takabumi Fujimura;
- Koji Mori;
- Jesse Hall;
- Xiaohong Yan;
- Zancong Shen;
- Sha Liu;
- Yasushi Ito;
- Baumgartner, Scott
Publication type:
Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
Published in:
Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2077, doi. 10.1093/infdis/jiab505
By:
- Peterson, James T;
- Zareba, Agnieszka M;
- Fitz-Patrick, David;
- Essink, Brandon J;
- Scott, Daniel A;
- Swanson, Kena A;
- Chelani, Dhawal;
- Radley, David;
- Cooper, David;
- Jansen, Kathrin U;
- Dormitzer, Philip R;
- Gruber, William C;
- Gurtman, Alejandra
Publication type:
Article

Found: 4

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.

Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).

Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials.

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.